FIELD: medicine; pharmacology.
SUBSTANCE: lyophilised preparation forms and solutions CCI-779 are available for production of lyophilised preparation forms CCI-779. The specified solutions consist of CCI-779 and solvent chosen from dimethylsulfoxide, acetonitrile, ethanol, isopropanol, tert-butyl alcohol and their mixtures. Besides, methods of lyophilised preparation forms CCI-779 preparation and restoration are offered.
EFFECT: improved storage stability and preservation of initial activity.
21 cl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RAPAMYCINE HYDROXY ETHERS-CONTAINING PARENTERAL COMPOSITIONS | 2003 |
|
RU2344821C2 |
| ANTI-TUMOR COMPOSITIONS CONTAINING RAPAMICINE DERIVATIVE AND AROMATASE INHIBITOR | 2004 |
|
RU2355399C2 |
| CCI-779 FOR AMPHICYTE LYMPHOMA TREATMENT | 2004 |
|
RU2358731C2 |
| LYOPHILIZED IMMUNOCYTOKINE-CONTAINING PREPARATION | 2003 |
|
RU2316348C2 |
| ECTEINASCIDIN AND DISACCHARIDE-CONTAINING COMPOSITIONS | 2005 |
|
RU2382647C2 |
| EPOTHILONE-CONTAINING COMPOSITIONS | 1999 |
|
RU2214246C2 |
| SOLID FORMS OF CEFTOLOZANE | 2014 |
|
RU2703457C2 |
| PHARMACEUTICAL COMPOSITION OF TAXAN, SOLID COMPOSITION OF TAXAN, METHOD OF PRODUCING SOLID COMPOSITION OF TAXAN, COMPOSITION FOR SOLUBILISATION OF SAID SOLID COMPOSITION OF TAXAN AND SET OF ELEMENTS (KIT) FOR COMPOSITION OF TAXAN FOR INJECTIONS | 2007 |
|
RU2429837C2 |
| METHOD OF PRODUCING BORTEZOMIB LYOPHILIZATE AND A PHARMACEUTICAL COMPOSITION CONTAINING BORTEZOMIB IN FORM OF A STABLE LYOPHILIZED PRODUCT OBTAINED BY SAID METHOD | 2018 |
|
RU2696854C1 |
| PHARMACEUTICAL ECHINOCANDINE PREPARATIONS CONTAINING MICELLE- FORMING SURFACE-ACTIVE AGENTS | 2000 |
|
RU2250763C2 |
